FROM PUBLIC EVENTS · 2026-11-15

Current stage

  1. Discovery · preclinical
  2. Early clinical · first deals
  3. Late clinical · capacity
  4. Commercial · sales
  1. Global approvals · expansion
  2. M&A · integration
  3. Pipeline reshaping

Commercial · sales Growing sales of its cardiac-arrest prediction AI in Korean hospitals.

  • Reported first-half sales of KRW 12.2 billion, of which DeepCARS KRW 10.4 billion. Source

Roles often seen at this stageData & AI · Regulatory affairs · Sales & marketing

Companies at the same stage and their people flow →

← Company library
Korea / Company briefSources checked 2026-11-15

VUNO

A medical-AI company whose in-hospital cardiac-arrest prediction product DeepCARS makes up most of its sales.

DeepCARS

Marketed

In-hospital cardiac-arrest prediction AI with first-half 2026 sales of KRW 10.4 billion.

Official role guide

VUNO careers

Current availability unconfirmed

Observed 2026-11-15

Work
Unconfirmed — The official careers page could not be confirmed.
Experience & requirements
Unconfirmed — The official careers page could not be confirmed.

Information from a role guide does not establish a current vacancy.

Sources & coverage 1

A brief based on selected official material, not an exhaustive product or vacancy list.

  1. 뷰노, 상반기 매출 122억원…딥카스 104억원 ↗네이트 뉴스 · Published 2026-08-14 · Sources checked 2026-11-15 · Original unavailable